Correlation Between SAB Biotherapeutics and LianBio ADR
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and LianBio ADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and LianBio ADR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and LianBio ADR, you can compare the effects of market volatilities on SAB Biotherapeutics and LianBio ADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of LianBio ADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and LianBio ADR.
Diversification Opportunities for SAB Biotherapeutics and LianBio ADR
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between SAB and LianBio is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and LianBio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LianBio ADR and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with LianBio ADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LianBio ADR has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and LianBio ADR go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and LianBio ADR
If you would invest 279.00 in SAB Biotherapeutics on September 13, 2024 and sell it today you would earn a total of 108.00 from holding SAB Biotherapeutics or generate 38.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
SAB Biotherapeutics vs. LianBio ADR
Performance |
Timeline |
SAB Biotherapeutics |
LianBio ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and LianBio ADR Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and LianBio ADR
The main advantage of trading using opposite SAB Biotherapeutics and LianBio ADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, LianBio ADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will offset losses from the drop in LianBio ADR's long position.SAB Biotherapeutics vs. Puma Biotechnology | SAB Biotherapeutics vs. Iovance Biotherapeutics | SAB Biotherapeutics vs. Sarepta Therapeutics | SAB Biotherapeutics vs. Day One Biopharmaceuticals |
LianBio ADR vs. Sensei Biotherapeutics | LianBio ADR vs. NextCure | LianBio ADR vs. Nuvation Bio | LianBio ADR vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |